Telltale Mouth Microbes

The composition of the plaque microbiome can reveal a child’s risk of dental caries months before the decay appears, according to a study.

Written byJyoti Madhusoodanan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Streptococcus mutansWIKIMEDIA, CDCWhen the human body changes as a result of disease, age, or other factors, site-specific microbiomes are also altered. Now, researchers report that changes in the oral microbial community can be used to predict the onset of dental caries in young children months before clinical signs of disease appear. The results, published today (September 9) in Cell Host & Microbe, suggest that changes to the oral microbiome can be used as an indicator of disease risk for some conditions.

The work is a “great contribution” to understanding how the oral microbiome develops in young children with and without caries, according to Elisabeth Bik, a microbiologist at the Stanford University School of Medicine who was not involved in the study.

Early childhood caries is the most common oral disease among children. Once it sets in, the disease is irreversible and places children at a higher risk of developing tooth decay as adults. Previous studies have attempted to identify markers correlated with the disease, including specific pathogens, oral hygiene habits, and sugar consumption, but these investigations failed to consistently equate these factors with the occurrence of caries. “Typically, a child’s risk of caries is best estimated based on past occurrence of the disease,” said study coauthor ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies